微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 15.08% | 1% | 57.91% | 8/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 9.55% | 1.49% | 136.39% | 8/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.04% | 2.02% | -76.07% | 12/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 16.88% | 1.32% | 13.06% | 7/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 14.93% | 4.26% | 58.66% | 6/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 9.41% | 6.21% | 137.63% | 8/158 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.96% | 5.32% | -76.23% | 20/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 16.66% | -3.48% | 16.34% | 15/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.32% | -5.85% | 61.63% | 13/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.86% | -8.19% | 135.64% | 19/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.76% | -5.76% | -78.22% | 21/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 17.26% | -3.84% | 13.48% | 14/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 15.21% | 5.11% | 57.62% | 12/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 9.65% | 3.54% | 141.85% | 17/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.99% | 6.68% | -77.77% | 21/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 17.95% | -2.29% | 24.05% | 27/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 14.47% | -10.46% | 55.26% | 17/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.32% | -8.63% | 149.2% | 23/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 3.74% | -9.88% | -79.64% | 24/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 18.37% | -0.7% | 13.68% | 23/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 16.16% | 1% | 58.43% | 12/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 10.2% | 0.2% | 145.78% | 15/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.15% | 2.22% | -77.57% | 17/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 18.5% | 17.91% | 15.63% | 22/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 16% | 4.3% | 57.17% | 8/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 10.18% | 6.6% | 150.74% | 11/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.06% | 1.75% | -74.12% | 15/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 15.69% | 2.21% | 2.28% | 22/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 15.34% | 16.39% | 60.63% | 13/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 9.55% | 5.52% | 139.35% | 17/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.99% | -38.8% | -74.01% | 13/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 15.35% | -13.42% | 16.46% | 36/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 13.18% | -30.67% | 45.64% | 16/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 9.05% | -31.54% | 38.8% | 18/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 6.52% | 16.64% | -63.23% | 7/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 17.73% | -25% | -6.73% | 27/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 19.01% | -4.18% | 43.8% | 7/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 13.22% | 1.85% | 136.49% | 8/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 5.59% | 0.72% | -76.35% | 8/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 23.64% | 2.69% | 19.15% | 14/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 19.84% | 1.43% | 52.85% | 6/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 12.98% | -4.07% | 133.87% | 4/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 5.55% | 1.83% | -75.89% | 9/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |